Tadao Ohno
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 59
- Immunotherapy and Immune Responses 47
- Immune Cell Function and Interaction 28
- T-cell and B-cell Immunology 10
-
- RNA Interference and Gene Delivery 8
- Co-authors
- Atsuo Ito (22 shared papers)Yu Sogo (21 shared papers)Xia Li (15 shared papers)Xiupeng Wang (15 shared papers)Kaoru Saijo (21 shared papers)Noriko M. Tsuji (10 shared papers)Yohei Watanabe (10 shared papers)Koji Tsuboi (13 shared papers)
- Journals
- Cancer Letters (5 papers)International Journal of Oncology (4 papers)Toxicology in Vitro (4 papers)World Journal of Surgical Oncology (4 papers)Journal of Cancer Research and Clinical Oncology (3 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Tadao Ohno
118 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 131
- Immunology 1.2k
- Oncology 759
- Biomaterials 308
- Pharmaceutical Science 142
- Genetics 210
Countries citing papers authored by Tadao Ohno
This map shows the geographic impact of Tadao Ohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadao Ohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadao Ohno more than expected).
Fields of papers citing papers by Tadao Ohno
This network shows the impact of papers produced by Tadao Ohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadao Ohno. The network helps show where Tadao Ohno may publish in the future.
Co-authors
The 25 scholars most cited alongside Tadao Ohno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 342 | |
| 2 | 1997 | 193 | |
| 3 | Autologous natural killer cell therapy for human recurrent malignant glioma. | 2004 | 167 |
| 4 | 2015 | 130 | |
| 5 | 1998 | 116 | |
| 6 | 2017 | 92 | |
| 7 | 2016 | 91 | |
| 8 | 1997 | 83 | |
| 9 | 1995 | 82 | |
| 10 | 2016 | 79 | |
| 11 | 2004 | 76 | |
| 12 | 2013 | 66 | |
| 13 | 2007 | 63 | |
| 14 | Effects of local injection of ex vivo expanded autologous tumor-specific T lymphocytes in cases with recurrent malignant gliomas. | 2003 | 61 |
| 15 | 2014 | 54 | |
| 16 | 2019 | 51 | |
| 17 | 2011 | 50 | |
| 18 | 1992 | 47 | |
| 19 | 1979 | 44 | |
| 20 | 2002 | 40 |
About Tadao Ohno
Tadao Ohno is a scholar working on Immunology, Molecular Biology, Oncology, Biomedical Engineering and Biotechnology, having authored 118 papers that have together received 3.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (47 papers), Immune Cell Function and Interaction (28 papers), Cancer Immunotherapy and Biomarkers (18 papers), Nanoplatforms for cancer theranostics (11 papers), T-cell and B-cell Immunology (10 papers), RNA Interference and Gene Delivery (8 papers), CAR-T cell therapy research (8 papers) and Bone Tissue Engineering Materials (6 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (759 citations), Biomaterials (308 citations), Pharmaceutical Science (142 citations) and Genetics (210 citations). Tadao Ohno has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Atsuo Ito, Yu Sogo, Xia Li, Xiupeng Wang, Kaoru Saijo, Noriko M. Tsuji, Yohei Watanabe, Koji Tsuboi, Eiichi Ishikawa and Shingo Takano. Their work appears in journals such as Cancer Letters, International Journal of Oncology, Toxicology in Vitro, World Journal of Surgical Oncology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.